Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Teverelix by Antev for Metastatic Prostate Cancer: Likelihood of Approval
Teverelix is under clinical development by Antev and currently in Phase II for Metastatic Prostate Cancer. According to GlobalData, Phase...
Teverelix by Antev for Hormone-Sensitive Prostate Cancer: Likelihood of Approval
Teverelix is under clinical development by Antev and currently in Phase II for Hormone-Sensitive Prostate Cancer. According to GlobalData, Phase...
Teverelix by Antev for Benign Prostatic Hyperplasia: Likelihood of Approval
Teverelix is under clinical development by Antev and currently in Phase II for Benign Prostatic Hyperplasia. According to GlobalData, Phase...
Teverelix by Antev for Urinary Retention: Likelihood of Approval
Teverelix is under clinical development by Antev and currently in Phase I for Urinary Retention. According to GlobalData, Phase I...